Access cutting-edge menopausal symptoms treatment through this clinical trial at a research site in Kansas City. Study-provided care at no cost to qualified participants.
Access menopausal symptoms specialists in Kansas City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related menopausal symptoms treatment provided free
Women at risk for development of breast cancer and experiencing vasomotor menopausal symptoms (hot flashes) will be randomized to bazedoxifene (BZA) plus conjugated estrogens (CE) for 6 months versus a wait list control. Two risk factors for development of breast cancer will be studied pre-study and after 6 months: fibroglandular volume (FGV) on mammogram as assessed by Volpara software and proliferation by Ki-67 immunocytochemistry in benign breast tissue acquired by random periareolar fine nee
Sponsor: University of Kansas Medical Center
Check if you qualify for this menopausal symptoms clinical trial in Kansas City, KS
If you're searching for menopausal symptoms treatment options in Kansas City, KS, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Kansas City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced menopausal symptoms specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.